October 11, 2023 10:38 AM EDT

Microbiome startup sells off assets; Faron's PhI/II data in bone marrow cancer; AM Pharma touts biomarker results

Kyle LaHucik

Senior Reporter

Lei Lei Wu

News Reporter

Microbiome startup sells assets, goes dark: Federation Bio sold some of its assets and erased its website three years since emerging with $50 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Microbiome startup sells off assets; Faron's PhI/II data in bone marrow cancer; AM Pharma touts biomarker results

Kyle LaHucik

Senior Reporter

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Are programs with compounded GLP-1s safe for your population?

Mi­cro­bio­me start­up sells off as­sets; Faron's PhI/II da­ta in bone mar­row can­cer; AM Phar­ma touts bio­mark­er re­sults

Senior Reporter

News Reporter

Sign up to read this article for free.

Microbiome startup sells off assets; Faron's PhI/II data in bone marrow cancer; AM Pharma touts biomarker results